Market Cap (In CNY)
4.74 Billion
Revenue (In CNY)
10.38 Billion
Net Income (In CNY)
292.16 Million
Avg. Volume
8.44 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 4.96-11.28
- PE
- -
- EPS
- -
- Beta Value
- 0.504
- ISIN
- CNE000000G05
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Weidong Zhu
- Employee Count
- -
- Website
- https://www.hyrmtt.com.cn
- Ipo Date
- 1994-02-24
- Details
- HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers Chinese medicines, Chinese herbal medicine, chemical preparations, antibiotics, biological products, and biochemical drugs, as well as medical equipment and health products. It also provides logistics services, including warehousing and distribution; and hospital services comprising medical treatment, scientific research, prevention, health care, rehabilitation, blood purification, and renal disease treatment. In addition, the company offers Chinese and Western medicines, Chinese herbal medicines, nourishing health care products, medical equipment, cosmetics, and daily necessities through an e-commerce platform. It operates 319 chain stores in Heilongjiang Province. The company was founded in 1950 and is headquartered in Harbin, China. HPGC Renmintongtai Pharmaceutical Corporation is a subsidiary of Harbin Pharmaceutical Group Co., Ltd.
More Stocks
-
PMMP
-
000230Ildong Holdings Co., Ltd.
000230
-
DGN
-
VASTVast Resources plc
VAST
-
688256
-
600216Zhejiang Medicine Co., Ltd.
600216
-
FLEW
-
GAME